Name: Net Profit Margin

Definition: Net profit margin shows how much profit remains after paying all costs — including operating expenses, interest, and taxes — for every dollar of sales. A higher margin means the business is efficient and keeps more of its sales as bottom-line profit. Falling margins may signal rising costs or pricing pressure.

Interpretation:
• In '2022', MGRX's net profit margin was -22352.1%, measuring the overall profitability of the company. Industry average for Misc Health and Biotechnology Services in '2022' stood at -30.8%.
• In '2023', MGRX's net profit margin was -1259.4%, measuring the overall profitability of the company. The increase since '2022' reflects strengthening financial performance. Industry average for Misc Health and Biotechnology Services in '2023' stood at -20.7%. Industry average increased by 10.1% compared to previous year.
• In '2024', MGRX's net profit margin was -1413.6%, measuring the overall profitability of the company. The decline from '2023' may indicate some operational or financial challenges. Industry average for Misc Health and Biotechnology Services in '2024' stood at -21.5%. Industry average declined by 0.8% from previous year.
Overall, MGRX's net profit margin has been volatile but showed an upward trend over the past 3 years.

Formula: Net Profit Margin = Net Income / Revenue

Good Range: Ranges 5%-20% for many industries.